Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9441 - 9448 of 11442 results
Three Take-Aways from the SEC's Six-Month Report on Administrative Proceedings
October 31, 2014| Blog| Viewpoint
The Contraception Coverage Controversy Continues…
October 31, 2014| Blog| Viewpoint
The EEOC Continues to Challenge Employer Wellness Programs Through Litigation
October 31, 2014| Blog| Viewpoint
Managing Antitrust Risks in Pre-Transaction Planning
October 30, 2014| Blog| Viewpoint
HHS Announces $840 Million Initiative to Improve Patient Care and Lower Healthcare Costs
October 30, 2014| Blog| Viewpoint
How to Tailor Your Strategies for Engaging With Shareholder Activists
October 30, 2014| Blog| Viewpoint
“Why, I declare” … Proper Use of Evidentiary Declarations under New (Post-AIA) Rule 37 C.F.R. 1.130
October 30, 2014| Advisory| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.